Cargando…
Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review
Autores principales: | Manti, Sara, Parisi, Giuseppe Fabio, Papale, Maria, Marseglia, Gian Luigi, Licari, Amelia, Leonardi, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860524/ https://www.ncbi.nlm.nih.gov/pubmed/33434384 http://dx.doi.org/10.1002/iid3.384 |
Ejemplares similares
-
Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab
por: Doan, Serge, et al.
Publicado: (2023) -
Type 2 inflammation in cystic fibrosis: New insights
por: Manti, Sara, et al.
Publicado: (2022) -
Management of Vernal Keratoconjunctivitis
por: Leonardi, Andrea
Publicado: (2013) -
Lower Airway Microbiota
por: Pulvirenti, Giulio, et al.
Publicado: (2019) -
Omalizumab in Children
por: Licari, Amelia, et al.
Publicado: (2014)